{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T02:29:39Z","timestamp":1770690579789,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:00:00Z","timestamp":1620086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:00:00Z","timestamp":1620086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["#201098WFZ2"],"award-info":[{"award-number":["#201098WFZ2"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["#201098WFZ2"],"award-info":[{"award-number":["#201098WFZ2"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EFSD Mentorship Programme Funded by AstraZeneca"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s12020-021-02736-8","type":"journal-article","created":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T21:07:50Z","timestamp":1620162470000},"page":"339-346","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Association of bone biomarkers with advanced atherosclerotic disease in people with overweight\/obesity"],"prefix":"10.1007","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8925-4020","authenticated-orcid":false,"given":"Rossella","family":"Del Toro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Cavallari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavia","family":"Tramontana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoungmin","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocky","family":"Strollo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana","family":"Valente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariangela","family":"De Pascalis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Grigioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Pozzilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Buzzetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Napoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto","family":"Maddaloni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,4]]},"reference":[{"issue":"6801","key":"2736_CR1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/35025203","volume":"407","author":"AJ Lusis","year":"2000","unstructured":"A.J. Lusis, Atherosclerosis. Nature 407(6801), 233\u2013241 (2000)","journal-title":"Nature"},{"issue":"4","key":"2736_CR2","doi-asserted-by":"publisher","first-page":"e3134","DOI":"10.1002\/dmrr.3134","volume":"35","author":"HCH Ho","year":"2019","unstructured":"H.C.H. Ho, E. Maddaloni, R. Buzzetti, Risk factors and predictive biomarkers of early cardiovascular disease in obese youth. Diabetes Metab. Res. Rev. 35(4), e3134 (2019)","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"2","key":"2736_CR3","first-page":"117","volume":"11","author":"D Sprini","year":"2014","unstructured":"D. Sprini, G.B. Rini, L. Di Stefano, L. Cianferotti, N. Napoli, Correlation between osteoporosis and cardiovascular disease. Clin. Cases Min. Bone Metab. 11(2), 117\u2013119 (2014)","journal-title":"Clin. Cases Min. Bone Metab."},{"issue":"9","key":"2736_CR4","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.1210\/jc.2003-030964","volume":"89","author":"E Schulz","year":"2004","unstructured":"E. Schulz, K. Arfai, X. Liu, J. Sayre, V. Gilsanz, Aortic calcification and the risk of osteoporosis and fractures. J. Clin. Endocrinol. Metab. 89(9), 4246\u20134253 (2004)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"2736_CR5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/BF02390833","volume":"68","author":"DP Kiel","year":"2001","unstructured":"D.P. Kiel, L.I. Kauppila, L.A. Cupples, M.T. Hannan, C.J. O\u2019Donnell, P.W. Wilson, Bone loss and the progression of abdominal aortic calcification over a 25 year period: the Framingham Heart Study. Calcif. Tissue Int. 68(5), 271\u2013276 (2001)","journal-title":"Calcif. Tissue Int."},{"issue":"5","key":"2736_CR6","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00592-017-0973-2","volume":"54","author":"E Maddaloni","year":"2017","unstructured":"E. Maddaloni, S. D\u2019Eon, S. Hastings, L.J. Tinsley, N. Napoli, M. Khamaisi, M.L. Bouxsein, S.M.R. Fouda, H.A. Keenan, Bone health in subjects with type 1 diabetes for more than 50 years. Acta Diabetol. 54(5), 479\u2013488 (2017)","journal-title":"Acta Diabetol."},{"key":"2736_CR7","first-page":"690783","volume":"2014","author":"N Napoli","year":"2014","unstructured":"N. Napoli, R. Strollo, A. Paladini, S.I. Briganti, P. Pozzilli, S. Epstein, The alliance of mesenchymal stem cells, bone, and diabetes. Int. J. Endocrinol. 2014, 690783 (2014)","journal-title":"Int. J. Endocrinol."},{"issue":"3","key":"2736_CR8","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00198-006-0282-z","volume":"18","author":"LC Hofbauer","year":"2007","unstructured":"L.C. Hofbauer, C.C. Brueck, C.M. Shanahan, M. Schoppet, H. Dobnig, Vascular calcification and osteoporosis-from clinical observation towards molecular understanding. Osteoporos. Int. 18(3), 251\u2013259 (2007)","journal-title":"Osteoporos. Int."},{"issue":"10","key":"2736_CR9","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s11892-018-1060-y","volume":"18","author":"S Pieralice","year":"2018","unstructured":"S. Pieralice, F. Vigevano, R. Del Toro, N. Napoli, E. Maddaloni, Lifestyle management of diabetes: implications for the bone-vascular axis. Curr. Diab Rep. 18(10), 84 (2018)","journal-title":"Curr. Diab Rep."},{"issue":"1","key":"2736_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.amjcard.2017.03.265","volume":"120","author":"CP McCarthy","year":"2017","unstructured":"C.P. McCarthy, R.R.J. van Kimmenade, H.K. Gaggin et al. Usefulness of multiple biomarkers for predicting incident major adverse cardiac events in patients who underwent diagnostic coronary angiography (from the Catheter Sampled Blood Archive in Cardiovascular Diseases [CASABLANCA] Study). Am. J. Cardiol. 120(1), 25\u201332 (2017)","journal-title":"Am. J. Cardiol."},{"issue":"9","key":"2736_CR11","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.2337\/dc14-0065","volume":"37","author":"D Gordin","year":"2014","unstructured":"D. Gordin, C. Forsblom, N.M. Panduru et al. Osteopontin is a strong predictor of incipient diabetic nephropathy, cardiovascular disease, and all-cause mortality in patients with type 1 diabetes. Diabetes Care 37(9), 2593\u20132600 (2014)","journal-title":"Diabetes Care"},{"issue":"6","key":"2736_CR12","doi-asserted-by":"crossref","first-page":"e003048","DOI":"10.1161\/JAHA.115.003048","volume":"5","author":"J van der Leeuw","year":"2016","unstructured":"J. van der Leeuw, J.W.J. Beulens, S. van Dieren et al. Novel biomarkers to improve the prediction of cardiovascular event risk in type 2 diabetes mellitus. J. Am. Heart Assoc. 5(6), e003048 (2016)","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"2736_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12933-018-0691-2","volume":"17","author":"SR Zwakenberg","year":"2018","unstructured":"S.R. Zwakenberg, Y.T. van der Schouw, C.G. Schalkwijk, A.M.W. Spijkerman, J.W.J. Beulens, Bone markers and cardiovascular risk in type 2 diabetes patients. Cardiovasc. Diabetol. 17(1), 45 (2018)","journal-title":"Cardiovasc. Diabetol."},{"issue":"6655","key":"2736_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/36285","volume":"390","author":"M Kuro-o","year":"1997","unstructured":"M. Kuro-o, Y. Matsumura, H. Aizawa et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390(6655), 45\u201351 (1997)","journal-title":"Nature"},{"issue":"1","key":"2736_CR15","doi-asserted-by":"crossref","first-page":"e3217","DOI":"10.1002\/dmrr.3217","volume":"36","author":"L D\u2019Onofrio","year":"2020","unstructured":"L. D\u2019Onofrio, E. Maddaloni, R. Buzzetti, Osteocalcin and sclerostin: background characters or main actors in cardiovascular disease? Diabetes Metab. Res Rev. 36(1), e3217 (2020)","journal-title":"Diabetes Metab. Res Rev."},{"issue":"1","key":"2736_CR16","doi-asserted-by":"publisher","first-page":"e3069","DOI":"10.1002\/dmrr.3069","volume":"35","author":"G Leto","year":"2019","unstructured":"G. Leto, L. D\u2019Onofrio, F. Lucantoni, S. Zampetti, G. Campagna, C. Foffi, C. Moretti, A. Carlone, A. Palermo, M. Leopizzi, N. Porta, M. Massucci, A. Lenzi, G.B. Bertoletti, C.D. Rocca, R. Buzzetti, Sclerostin is expressed in the atherosclerotic plaques of patients who undergoing carotid endarterectomy. Diabetes Metab. Res. Rev. 35(1), e3069 (2019)","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"5","key":"2736_CR17","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1210\/jc.2017-02274","volume":"103","author":"N Napoli","year":"2018","unstructured":"N. Napoli, R. Strollo, G. Defeudis, G. Leto, C. Moretti, S. Zampetti, L. D\u2019Onofrio, G. Campagna, A. Palermo, V. Greto, S. Manfrini, M.I. Hawa, R.D. Leslie, P. Pozzilli, R. Buzzetti, NIRAD (NIRAD 10) and Action LADA Study Groups. Serum sclerostin and bone turnover in latent autoimmune diabetes in adults. J. Clin. Endocrinol. Metab. 103(5), 1921\u20131928 (2018)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"2736_CR18","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1111\/dom.13788","volume":"21","author":"E Maddaloni","year":"2019","unstructured":"E. Maddaloni, R.L. Coleman, P. Pozzilli, R.R. Holman, Long-term risk of cardiovascular disease in individuals with latent autoimmune diabetes in adults (UKPDS 85). Diabetes Obes. Metab. 21(9), 2115\u20132122 (2019)","journal-title":"Diabetes Obes. Metab."},{"key":"2736_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bone.2016.10.007","volume":"96","author":"J Delgado-Calle","year":"2017","unstructured":"J. Delgado-Calle, A.Y. Sato, T. Bellido, Role and mechanism of action of sclerostin in bone. Bone Mar. 96, 29\u201337 (2017)","journal-title":"Bone Mar."},{"issue":"6","key":"2736_CR20","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.amjcard.2016.06.044","volume":"118","author":"E Maddaloni","year":"2016","unstructured":"E. Maddaloni, I. Cavallari, M. De Pascalis et al. Relation of body circumferences to cardiometabolic disease in overweight-obese subjects. Am. J. Cardiol. 118(6), 822\u2013827 (2016)","journal-title":"Am. J. Cardiol."},{"issue":"5","key":"2736_CR21","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/sim.3513","volume":"28","author":"CF Burman","year":"2009","unstructured":"C.F. Burman, C. Sonesson, O. Guilbaud, A recycling framework for the construction of Bonferroni-based multiple tests. Stat. Med. 28(5), 739\u2013761 (2009)","journal-title":"Stat. Med."},{"key":"2736_CR22","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","volume":"12","author":"N Bucat","year":"1998","unstructured":"N. Bucat et al. Osteoprotegerin deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 12, 1260\u20131268 (1998)","journal-title":"Genes Dev."},{"issue":"2","key":"2736_CR23","first-page":"606","volume":"204","author":"M Shargorosky","year":"2009","unstructured":"M. Shargorosky et al. Osteoprotegerin as an independent marker of subclinical atherosclerosis in osteoporotic postmenopausal women. Atherosclerosis 204(2), 606\u2013611 (2009)","journal-title":"Atherosclerosis"},{"issue":"3","key":"2736_CR24","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1210\/jc.2002-020775","volume":"88","author":"M Schoppet","year":"2003","unstructured":"M. Schoppet et al. Increased osteoprotegerin serum levels in men with coronary artery disease. J. Clin. Endocrinol. Metab. 88(3), 1024\u20131028 (2003)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"18","key":"2736_CR25","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1161\/01.CIR.0000127957.43874.BB","volume":"109","author":"S Kiechl","year":"2004","unstructured":"S. Kiechl et al. Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease. Circulation 109(18), 2175\u20132180 (2004)","journal-title":"Circulation"},{"issue":"3","key":"2736_CR26","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.metabol.2007.10.005","volume":"57","author":"D Siepi","year":"2008","unstructured":"D. Siepi et al. Preclinical vascular damage in white menopausal women: the relevance of osteoprotegerin. Metabolism 57(3), 321\u2013325 (2008)","journal-title":"Metabolism"},{"issue":"2","key":"2736_CR27","first-page":"631","volume":"86","author":"WS Browner","year":"2001","unstructured":"W.S. Browner et al. Associations of serum osteoprotegerin level with diabetes, stroke, bone density, fractures, and mortality in elderly women. J. Clin. Endocrinol. Metab. 86(2), 631\u2013637 (2001)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"2736_CR28","doi-asserted-by":"publisher","first-page":"108124","DOI":"10.1016\/j.celrep.2020.108124","volume":"32","author":"M Tsukasaki","year":"2020","unstructured":"M. Tsukasaki, T. Asano, R. Muro, N.C. Huynh, N. Komatsu, K. Okamoto, K. Nakano, T. Okamura, T. Nitta, H. Takayanagi, OPG Production Matters Where It Happened. Cell Rep. 32(10), 108124 (2020)","journal-title":"Cell Rep."},{"issue":"6","key":"2736_CR29","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.2337\/dc12-1691","volume":"36","author":"S Morales-Santana","year":"2013","unstructured":"S. Morales-Santana, B. Garcia-Fontana, A. Garcia-Martin, P. Rozas-Moreno, J.A. Garcia-Salcedo, R. Reyes-Garcia et al. Atherosclerotic disease in type 2 diabetes is associated with an increase in sclerostin levels. Diabetes Care 36(6), 1667\u20131674 (2013)","journal-title":"Diabetes Care"},{"key":"2736_CR30","doi-asserted-by":"crossref","unstructured":"A. Piccoli, F. Cannata, R. Strollo, C. Pedone, G. Leanza, F. Russo, V. Greto, C. Isgr\u00f2, C. Quattrocchi, C.C. Massaroni, S. Silvestri, G. Vadal\u00e0, T. Bisogno, V. Denaro, P. Pozzilli., S.Y. Tang, M.J. Silva M. J., C. Conte, R. Papalia, M. Maccarrone, N. Napoli. Sclerostin regulation, microarchitecture, and advanced glycation end-products in the bone of elderly women with type 2 diabetes. J. Bone Miner. Res. 35(12), 2415\u20132422 (2020)","DOI":"10.1002\/jbmr.4153"},{"key":"2736_CR31","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","volume":"377","author":"KG Saag","year":"2017","unstructured":"K.G. Saag et al. Romosozumab or alendronate for fracture prevention in women with osteoporosis. N. Engl. J. Med. 377, 1417\u20131427 (2017)","journal-title":"N. Engl. J. Med."},{"key":"2736_CR32","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.omtm.2020.08.002","volume":"18","author":"H Gu","year":"2020","unstructured":"H. Gu, W. Jiang, N. You, X. Huang, Y. Li, X. Peng, R. Dong, Z. Wang, Y. Zhu, K. Wu, J. Li, L. Zheng, Soluble klotho improves hepatic glucose and lipid homeostasis in type 2 diabetes. Mol. Ther. Methods Clin. Dev. 5; 18, 811\u2013823 (2020)","journal-title":"Mol. Ther. Methods Clin. Dev. 5;"},{"issue":"4","key":"2736_CR33","doi-asserted-by":"publisher","first-page":"e01494","DOI":"10.1016\/j.heliyon.2019.e01494","volume":"24;5","author":"Z Rao","year":"2019","unstructured":"Z. Rao, T. Landry, P. Li, W. Bunner, B.T. Laing, Y. Yuan, H. Huang, Administration of alpha klotho reduces liver and adipose lipid accumulation in obese mice. Heliyon 24;5(4), e01494 (2019)","journal-title":"Heliyon"},{"key":"2736_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.tem.2014.10.002","volume":"26","author":"BM Owen","year":"2015","unstructured":"B.M. Owen, D.J. Mangelsdorf, S.A. Kliewer, Tissue-specific actions of the metabolic hormones FGF15\/19 and FGF21. Trends Endocrinol. Metab. 26, 22\u201329 (2015)","journal-title":"Trends Endocrinol. Metab."},{"issue":"3","key":"2736_CR35","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s12020-009-9181-3","volume":"35","author":"Y Maekawa","year":"2009","unstructured":"Y. Maekawa, K. Ishikawa, O. Yasuda, R. Oguro, H. Hanasaki, I. Kida et al. Klotho suppresses TNF-alpha-induced expression of adhesion molecules in the endothelium and attenuates NF-kappaB activation. Endocrine 35(3), 341\u2013346 (2009)","journal-title":"Endocrine"},{"issue":"1-2","key":"2736_CR36","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.mce.2012.05.002","volume":"361","author":"M Tsubaki","year":"2012","unstructured":"M. Tsubaki, T. Satou, T. Itoh, M. Imano, M. Yanae, C. Kato et al. Bisphosphonate- and statin-induced enhancement of OPG expression and inhibition of CD9, M-CSF, and RANKL expressions via inhibition of the Ras\/MEK\/ERK pathway and activation of p38MAPK in mouse bone marrow stromal cell line ST2. Mol. Cell. Endocrinol. 361(1-2), 219\u2013231 (2012)","journal-title":"Mol. Cell. Endocrinol."},{"issue":"6","key":"2736_CR37","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/j.bone.2007.02.019","volume":"40","author":"B Uzzan","year":"2007","unstructured":"B. Uzzan, R. Cohen, P. Nicolas, M. Cucherat, G.Y. Perret, Effects of statins on bone mineral density: a meta-analysis of clinical studies. Bone 40(6), 1581\u20131587 (2007)","journal-title":"Bone"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02736-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-021-02736-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02736-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T07:43:03Z","timestamp":1698997383000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-021-02736-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,4]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["2736"],"URL":"https:\/\/doi.org\/10.1007\/s12020-021-02736-8","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,4]]},"assertion":[{"value":"27 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}